810220 | C6-NBD Galactosyl Ceramide

N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-galactosyl-ß1-1'-sphingosine


Chloroform

Size SKU Packaging Price
250µg 810220C-250ug 810220C-250ug $1,110.00

Powder

Size SKU Packaging Price
250µg 810220P-250ug 810220P-250ug $1,110.00
Base Price: ${originalprice|money}
Custom Packaging: (${concentration} @$4.00/ea. + $100) ${custompackagingtotal|money}
Packaging: ${concentration}
Item Total: ${totalprice|money}
(Sales Tax may apply)
Please select an option above.
${sku} - ${concentration}

C6-NBD Galactosyl Ceramide

C6-NBD Galactosyl Ceramide

N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-galactosyl-ß1-1'-sphingosine

Hygroscopic
Yes
Light Sensitive
Yes
Molecular Formula
C36H59N5O11
Percent Composition
C 58.60%, H 8.06%, N 9.49%, O 23.85%
Purity
>99%
Stability
1 Year
Storage Temperature
-20°C
CAS Number
170212-26-7
CAS Registry Number is a Registered Trademark of the American Chemical Society
Formula Weight
737.881
Exact Mass
737.421

Ben-David O, Pewzner-Jung Y, Brenner O, Laviad EL, Kogot-Levin A, Weissberg I, Biton IE, Pienik R, Wang E, Kelly S, Alroy J, Raas-Rothschild A, Friedman A, Brügger B, Merrill AH Jr, Futerman AH. Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels. J Biol Chem. 2011 Aug 26;286(34):30022-33. doi: 10.1074/jbc.M111.261206. Epub 2011 Jun 24. PMID: 21705317; PMCID: PMC3191043.

PubMed ID: 21705317